US Stock MarketDetailed Quotes
SUPN Supernus Pharmaceuticals
- 34.700
- +0.730+2.15%
Close Nov 4 16:00 ET
- 37.000
- +2.300+6.63%
Post 18:42 ET
1.91BMarket Cap385.56P/E (TTM)
34.960High33.700Low450.39KVolume33.960Open33.970Pre Close15.64MTurnover0.95%Turnover Ratio1735.00P/E (Static)55.11MShares35.56052wk High2.00P/B1.65BFloat Cap25.53052wk Low--Dividend TTM47.48MShs Float61.250Historical High--Div YieldTTM3.71%Amplitude4.300Historical Low34.730Avg Price1Lot Size
Supernus Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 288.75%35.62M | -21.83%38.4M | -4.91%111.09M | 63.10%44.96M | 159.19%35.88M | -126.54%-18.87M | 1,041.93%49.13M | -8.10%116.83M | -43.47%27.56M | 436.76%13.84M |
| Net income from continuing operations | 2,496.63%19.92M | -99.27%124K | -97.83%1.32M | -95.39%1.18M | -1,013.44%-15.98M | -110.57%-831K | -33.84%16.95M | 13.64%60.71M | 943.45%25.48M | -91.89%1.75M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 95.97%-14K | --0 | 50.00%-1K |
| Depreciation and amortization | -0.03%20.72M | 0.72%20.75M | -0.80%84.86M | 3.97%21.68M | 0.38%21.86M | -3.86%20.73M | -3.56%20.6M | 162.44%85.54M | 64.07%20.85M | 226.22%21.78M |
| Deferred tax | -46.11%-8.12M | -1,160.23%-5.48M | 2.32%-25.71M | -34.78%-10.46M | -269.61%-9.27M | -82.34%-5.55M | 96.66%-435K | -427.11%-26.32M | -71.87%-7.76M | -259.99%-2.51M |
| Other non cash items | -102.68%-181K | 0.74%1.35M | 3,574.72%12.94M | 81.41%3.23M | -84.27%1.6M | 675,900.00%6.76M | 111.57%1.34M | -98.57%352K | -57.45%1.78M | 99.16%10.19M |
| Change In working capital | 93.72%-2.9M | 155.91%13.87M | 62.31%-9.14M | 111.57%1.97M | 221.14%29.67M | -218.36%-46.2M | 124.95%5.42M | -779.08%-24.24M | -159.32%-17.07M | 45.06%-24.49M |
| -Change in receivables | -208.35%-4.76M | -116.29%-3.58M | 214.66%18.77M | -69.74%-2.39M | 11.18%-5.21M | 134.04%4.39M | 476.36%21.97M | -523.22%-16.37M | 59.60%-1.41M | -256.53%-5.87M |
| -Change in inventory | 251.42%6.03M | 207.51%1.99M | 134.21%6.11M | 143.52%5.03M | 184.85%6.91M | -192.32%-3.98M | 25.00%-1.85M | -22.48%-17.86M | -120.12%-11.55M | -489.86%-8.15M |
| -Change in prepaid assets | 102.58%728K | -2,104.40%-7.52M | -102.71%-334K | -15.22%7.8M | 1,556.33%20.41M | -3,603.48%-28.2M | -132.14%-341K | 246.50%12.3M | 85.85%9.21M | -73.52%1.23M |
| -Change in payables and accrued expense | 73.41%-4.9M | 259.95%22.97M | -15,070.27%-33.68M | 36.37%-8.47M | 164.55%7.56M | -139.32%-18.41M | 34.79%-14.36M | -100.98%-222K | -140.89%-13.31M | 77.30%-11.71M |
| -Change in other current liabilities | ---- | ---- | --0 | --0 | ---- | ---- | ---- | ---2.1M | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 288.75%35.62M | -21.83%38.4M | -4.91%111.09M | 63.10%44.96M | 159.19%35.88M | -126.54%-18.87M | 1,041.93%49.13M | -8.10%116.83M | -43.47%27.56M | 436.76%13.84M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -180.59%-48.59M | -121.53%-51.62M | 224.03%268.73M | -35.30%-65.98M | 142.12%34.63M | 484.57%60.3M | 442.61%239.78M | -164.50%-216.66M | -164.05%-48.77M | -1,341.65%-82.23M |
| Net PPE purchase and sale | 59.75%-64K | 10.79%-248K | -33.74%-551K | 260.00%36K | -2.04%-150K | -127.60%-159K | 67.33%-278K | 79.85%-412K | 125.00%10K | -234.09%-147K |
| Net business purchase and sale | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Net investment purchase and sale | -180.27%-48.53M | -121.40%-51.38M | 224.52%269.28M | -35.35%-66.02M | 142.38%34.78M | 471.92%60.46M | 447.23%240.06M | -198.77%-216.25M | -113.04%-48.78M | -1,350.27%-82.09M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -180.59%-48.59M | -121.53%-51.62M | 224.03%268.73M | -35.30%-65.98M | 142.12%34.63M | 484.57%60.3M | 442.61%239.78M | -164.50%-216.66M | -164.05%-48.77M | -1,341.65%-82.23M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 100.35%1.66M | -98.04%1.57M | -3,697.65%-397.88M | -61.40%1.09M | -103.56%-230K | -21,169.78%-478.92M | 463.86%80.17M | 91.97%-10.48M | 102.07%2.83M | 387.54%6.46M |
| Net issuance payments of debt | --0 | --0 | ---402.5M | --0 | --0 | ---480.86M | --78.36M | --0 | --0 | --0 |
| Net common stock issuance | -34.22%1.66M | 28.99%2.91M | -46.79%6.61M | 8.94%3.08M | -119.36%-1.25M | 10.95%2.52M | 160.51%2.26M | 75.10%12.42M | 79.62%2.83M | 1,131.87%6.46M |
| Net other financing activities | 99.83%-1K | -201.12%-1.34M | 91.31%-1.99M | ---- | ---- | ---575K | 98.06%-445K | ---22.9M | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 100.35%1.66M | -98.04%1.57M | -3,697.65%-397.88M | -61.40%1.09M | -103.56%-230K | -21,169.78%-478.92M | 463.86%80.17M | 91.97%-10.48M | 102.07%2.83M | 387.54%6.46M |
| Net cash flow | ||||||||||
| Beginning cash position | -86.28%63.4M | -19.40%75.05M | -54.23%93.12M | -14.81%94.99M | -85.75%24.71M | 299.43%462.2M | -54.23%93.12M | -29.52%203.43M | -48.21%111.49M | -22.50%173.43M |
| Current changes in cash | 97.41%-11.31M | -103.16%-11.65M | 83.62%-18.07M | -8.49%-19.93M | 213.47%70.28M | -858.05%-437.49M | 520.75%369.08M | -29.47%-110.31M | -55.08%-18.37M | -629.52%-61.94M |
| End cash Position | 110.84%52.09M | -86.28%63.4M | -19.40%75.05M | -19.40%75.05M | -14.81%94.99M | -85.75%24.71M | 299.43%462.2M | -54.23%93.12M | -54.23%93.12M | -48.21%111.49M |
| Free cash flow | 286.83%35.56M | -21.89%38.15M | -5.05%110.53M | 63.18%44.99M | 160.88%35.73M | -126.55%-19.03M | 1,315.47%48.85M | -6.93%116.41M | -43.41%27.57M | 429.66%13.69M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data